MORTALITY PREVENTION IN SEPTIC MICE WITH MULTIPLE ORGAN DYSFUNCTION SYNDROME: THE OPTIMAL DOSE OF INTRAPERITONEAL HEAT SHOCK PROTEIN 70

Author:

Sukamto Igl,Purwanto Bambang,Mudigdo Ambar,Suroto Suroto,Murti Bhisma,Ayuningrum Ika Yuli

Abstract

Objective: Heat shock protein 70 (HSP70) reduces the expression of cytochrome C, B-cell lymphoma-associated X, and cysteine-aspartic acid protease 3 (Caspase 3), in apoptosis of multiple organ dysfunction syndrome (MODS), and thereby can prevent death. Previous researchers used 226 mg/kgBW/intraperitoneal (ip) of HSP70. This study aimed to determine the lowest effective dose of HSP70 to prevent death in sepsis mice model with MODS.Methods: This was a randomized control trial conducted at Pusat Antar Universitas (PAU), Gadjah Mada University, Yogyakarta, Indonesia, from April 1, 2017 to April 21, 2017. The study subjects were Balb/c strain mice. The drug used to induce death was lipopolysaccharides (LPS). The drug used to prevent death in this study was Rat HSP70. A sample of 25 mice was randomized into five groups with each consisting of five mice: (1) Control group with NaCl, (2) experimental group receiving LPS injection of 0.25 mg/kgBW/i.p, (3) experimental group receiving the same dose of LPS injection with HSP70 injection of 100 μg/kgBW/ip, (4) experimental group receiving the same dose of LPS injection with HSP70 injection of 200 μg/kgBW/ip, and (5) experimental group receiving the same dose of LPS injection with HSP70 injection of 300 μg/kgBW/ip. Percentage of live mice between groups was compared by Chi-square test.Results: 3 days after intervention, 13 (86.7%) live mice in the experimental group with ≥100 μg/kgBW/i.p HSP70 were >2 (40%) live mice in the experimental group with <100 μg/kgBW/i.p HSP70, with p=0.038. All mice receiving ≥200 μg/kgBW/ip HSP70 in the experimental group were Alive 3 days after intervention.Conclusion: The lowest effective dose of HSP70 to prevent death in sepsis mice model with MODS is 200 μg/kgBW/ip. All mice are alive 3 days after receiving ≥200 μg/kgBW/ip HSP70. 

Publisher

Innovare Academic Sciences Pvt Ltd

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3